Home › Melanoma › Connecticut › Hartford
Melanoma clinical trials in Hartford, CT
5 studies for Melanoma are looking for participants at sites in and around Hartford (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
RecruitingPhase 1/2
- Hartford Healthcare, Hartford
Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination With Pembrolizumab, in Unresectable Melanoma Patients
RecruitingPhase 2
- Hartford Hospital, Hartford
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Connecticut Children's Medical Center, Hartford
Integrated Cancer Repository for Cancer Research
RecruitingObservational studyHealthy volunteers welcome
- Hartford HealthCare Cancer Institute at Manchester Medical Hospital, Manchester · 8 mi away
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Hartford
About Melanoma
Melanoma is the most serious type of skin cancer. Most have a black or black-blue area. Learn the 'ABCDE' of what to watch for and treatment options.
More about Melanoma on MedlinePlus
Melanoma trials in other cities
- Houston, TX61 studies
- New York City, NY41 studies
- Nashville, TN34 studies
- Los Angeles, CA34 studies
- Pittsburgh, PA31 studies
- Boston, MA25 studies
- St. Louis, MO23 studies
- Durham, NC22 studies
- Philadelphia, PA22 studies
- Tampa, FL21 studies
- Columbus, OH21 studies
- Dallas, TX21 studies
Other studies in Hartford
- Non-Small Cell Lung Cancer11 studies
- Breast Cancer10 studies
- Lung Cancer10 studies
- Cancer (all types)9 studies
- Major Depressive Disorder8 studies
- Neuroblastoma8 studies
- Ovarian Cancer7 studies
- Prostate Cancer7 studies
- Heart Failure7 studies
- Multiple Myeloma7 studies
- Pancreatic Cancer7 studies
- Endometrial Cancer6 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.